Study Endpoints
The primary endpoint was a favourable neurological outcome
one month after cardiac arrest, defined a priori as a
Glasgow-Pittsburgh cerebral performance category 1 (good
performance) or 2 (moderate disability) [16]. The other categories
of 3 (severe cerebral disability), 4 (vegetative state),
and 5 (death) were regarded as unfavourable neurological
outcomes [16]. Secondary outcome measures were the
one-month survival and the ROSC before hospital arrival.